[(1S)-1-(5-Fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]carbamic acid 1,1-dimethylethyl ester CAS: 870281-85-9
| Product Parameters | |
|---|---|
| Catalog No. | BK554F |
| CAS.RN | 870281-85-9 |
| Molecular Formula | C22H24FN3O3 |
| Molecular Weight | 397.44 g/mol |
| Purity | NLT 98% |
Product Overview
(S)-tert-butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate is an important pharmaceutical intermediate widely used in the synthesis of antitumor, antiviral, and central nervous system drugs. This compound exhibits high structure specificity and reactivity, making it suitable for drug molecule skeleton construction and the preparation of key intermediates. It can meet the needs of small-scale, pilot-scale, and industrial-scale production in the R&D stage, providing customers with a stable and reliable raw material supply and supporting new drug development and process optimization.
Applications
- Drug molecular skeleton construction
- Synthetic intermediates for antitumor drugs
- Key precursors for antiviral drugs
- Development of central nervous system drugs
- Process route optimization and customized synthesis
Quality & Supply Capability
English Name: [(1S)-1-(5-Fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]carbamic acid 1,1-dimethylethyl ester Properties: This product is a white to off-white solid containing a quinazoline ring structure and carbamate functional groups. It exhibits good chemical stability and reactivity, making it suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust the supply plan according to the customer's requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documents. We also have a professional technical support team to assist customers in completing process development and route optimization from laboratory R&D to scale-up production, ensuring the smooth progress and transformation of projects.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing a rich product portfolio and accumulated technology. Full-scale supply capabilities, covering needs from laboratory to commercial production. Complete quality control documentation to ensure product compliance and consistency. Customized synthesis and process optimization services available to meet client needs. Supporting scale-up production technologies to help clients achieve efficient commercialization.
Intermediates of Idelalisib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA358W | Idelalisib API | 870281-82-6 |
| BK554F | [(1S)-1-(5-Fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]carbamic acid 1,1-dimethylethyl ester | 870281-85-9 |
| BK15Z4 | (S)-2-(1-aMinopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | 870281-86-0 |
| BK2WH9 | Boc-l-2-aminobutyric acid | 34306-42-8 |
| BK9DE2 | 2-Fluoro-6-nitro-N-phenylbenzamide | 870281-83-7 |
| BK391J | 2-Amino-5-fluoro-N-phenylbenzamide | 60041-89-6 |
| BK166W | 2-aMino-6-fluoro-N-phenylbenzaMide hydrochloride | 1417456-04-2 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 870281-85-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.